Vitrolife AB (publ) (VITR.ST)
- Previous Close
156.60 - Open
157.60 - Bid 162.70 x --
- Ask 162.90 x --
- Day's Range
157.50 - 164.00 - 52 Week Range
123.90 - 244.20 - Volume
95,014 - Avg. Volume
115,231 - Market Cap (intraday)
22.118B - Beta (5Y Monthly) 1.58
- PE Ratio (TTM)
-- - EPS (TTM)
-28.33 - Earnings Date Jul 12, 2024
- Forward Dividend & Yield 1.00 (0.61%)
- Ex-Dividend Date Apr 26, 2024
- 1y Target Est
228.75
Vitrolife AB (publ) provides assisted reproduction products. It also offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. In addition, the company offers EmbryoScope and time-lapse systems; time-lapse dishes; and evaluation tools for time-lapse systems. The company operates in Europe, the Middle East, India and Africa; Asia; Japan and Pacific; Americas; and Asia. Vitrolife AB (publ) was founded in 1994 and is based in Gothenburg, Sweden.
www.vitrolife.comRecent News: VITR.ST
Performance Overview: VITR.ST
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: VITR.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: VITR.ST
Valuation Measures
Market Cap
22.12B
Enterprise Value
23.24B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.32
Price/Book (mrq)
1.67
Enterprise Value/Revenue
6.64
Enterprise Value/EBITDA
-6.44
Financial Highlights
Profitability and Income Statement
Profit Margin
-109.63%
Return on Assets (ttm)
2.48%
Return on Equity (ttm)
-25.36%
Revenue (ttm)
3.5B
Net Income Avi to Common (ttm)
-3.84B
Diluted EPS (ttm)
-28.33
Balance Sheet and Cash Flow
Total Cash (mrq)
947M
Total Debt/Equity (mrq)
15.64%
Levered Free Cash Flow (ttm)
631.5M
Research Analysis: VITR.ST
Company Insights: VITR.ST
VITR.ST does not have Company Insights